So what's the label?

What did the fda say?

 

It does not mention highly emetogenic only moderately emetogenic chemotherapy and anthracycline and cyclophosphamide combination chemotherapy regimens

 

Disappointing news

 

Not really, AC is 93% of HEC so we are good to go. And no other drug in class even has that.

 

Can't wait to see the awesome sales force out there selling this dog. Can't wait for first full quarter of earninns with this dog. Stock will tumble

 

Lipstick on a pig

 

dendreon part deux

 

So. Very. True.

Train the nurses all you want. Nobody likes to get stuck with a large bore needle when it's Simply. Not. Necessary.

And G_d help the practice that forces this pain on patients for the profit of the GPO contract. Once that motivation gets out, the practice will have some serious 'splainin to do.

 

Beyond moderately emetogenic chemotherapy, Heron secured a claim in the Sustol label to cover acute and delayed nausea and vomiting associated with anthracycline and cyclophosphamide (AC) chemotherapy regimens. This is a narrower claim than all highly emetogenic chemotherapy (HEC).